ILMN
HealthcareIllumina, Inc.
Prev Close
$115.56
Open
$116.10
High
$120.41
Low
$116.10
Volume
1.28M
Market Cap
$18.19B
P/E
21.76
Div Yield
—
Over the past 12 months, insider activity at Illumina, Inc. (ILMN) has been dominated by selling, with 4 insider purchases totaling $1.58M and 18 insider sales totaling $83.28M. The most recent insider transaction was by Davies Scott M (officer: Chief Legal Officer), who sold $310.4K worth of shares on Feb 24, 2026. Illumina, Inc. operates in the Healthcare sector, within the Medical - Diagnostics & Research industry, with a market cap of $18.19B.
Buys (12M)
4
$1.58M
Sells (12M)
18
$83.28M
Net Activity
Net Seller
$81.70M
Active Insiders
11
last 12 mo
ILMN Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026↗ | Davies Scott M | officer: Chief Legal Officer | Sell | 2,672 | $116.18 | $310.4K | 16,334 |
| Feb 18, 2026↗ | Leckman Patricia | officer: SVP, Chief People Officer | Sell | 2,370 | $116.18 | $275.3K | 16,321 |
| Feb 17, 2026↗ | Ericksen Scott D | VP, Chief Accounting Officer | Sell | 306 | $114.44 | $35.0K | 0 |
| Feb 15, 2026↗ | Barnard Steven | SVP, Chief Technology Officer | Sell | 1,259 | $116.51 | $146.7K | 0 |
| Feb 15, 2026↗ | Davies Scott M | Chief Legal Officer | Sell | 1,037 | $116.51 | $120.8K | 0 |
| Feb 15, 2026↗ | Ericksen Scott D | VP, Chief Accounting Officer | Sell | 694 | $116.51 | $80.9K | 0 |
| Feb 15, 2026↗ | Leckman Patricia | SVP, Chief People Officer | Sell | 3,674 | $116.30 | $427.3K | 0 |
| Feb 15, 2026↗ | Pegels Kevin Carl | Chief of Global Operations | Sell | 1,164 | $116.51 | $135.6K | 0 |
| Feb 15, 2026↗ | Thaysen Jacob | Chief Executive Officer | Sell | 6,544 | $116.51 | $762.4K | 0 |
| Feb 15, 2026↗ | Wedel Christensen Jakob | SVP, Strategy/Corp Development | Sell | 578 | $116.51 | $67.3K | 0 |
| Feb 12, 2026↗ | Barnard Steven | SVP, Chief Technology Officer | Sell | 1,014 | $114.44 | $116.0K | 0 |
| Feb 12, 2026↗ | Davies Scott M | Chief Legal Officer | Sell | 550 | $114.44 | $62.9K | 0 |
| Feb 12, 2026↗ | Leckman Patricia | SVP, Chief People Officer | Sell | 424 | $114.44 | $48.5K | 0 |
| Feb 12, 2026↗ | Pegels Kevin Carl | Chief of Global Operations | Sell | 874 | $114.44 | $100.0K | 0 |
| Feb 12, 2026↗ | Thaysen Jacob | Chief Executive Officer | Sell | 5,470 | $114.44 | $626.0K | 0 |
| Feb 11, 2026↗ | Gottlieb Scott | director | Buy | 200 | $117.81 | $23.6K | 12,723 |
| Dec 16, 2025↗ | Davies Scott M | Chief Legal Officer | Sell | 323 | $136.09 | $44.0K | 17,887 |
| Dec 9, 2025↗ | Wedel Christensen Jakob | SVP, Strategy/Corp Development | Sell | 549 | $129.27 | $71.0K | 10,952 |
| Nov 18, 2025↗ | ILLUMINA, INC. | Sell | 1,000,000 | $79.85 | $79.85M | 3,502,130 | |
| Nov 5, 2025↗ | Gottlieb Scott | Director | Buy | 500 | $122.13 | $61.1K | 12,523 |
| May 14, 2025↗ | Dhingra Ankur | SVP, Chief Financial Officer | Buy | 6,100 | $81.21 | $495.4K | 24,906 |
| May 14, 2025↗ | Thaysen Jacob | Chief Executive Officer | Buy | 12,350 | $80.86 | $998.7K | 83,390 |
| Feb 26, 2024↗ | Thaysen Jacob | Chief Executive Officer | Buy | 7,330 | $135.29 | $991.7K | 14,861 |
| Nov 9, 2023↗ | Hoyt Aimee L | SVP, Chief People Officer | Sell | 315 | $112.84 | $35.5K | 8,314 |
| Aug 24, 2023↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 500 | $167.04 | $83.5K | 45,524 |
| Jul 26, 2023↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 500 | $190.08 | $95.0K | 46,022 |
| Jun 26, 2023↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 500 | $200.00 | $100.0K | 46,522 |
| May 24, 2023↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 5,000 | $208.59 | $1.04M | 51,822 |
| Mar 3, 2023↗ | Hoyt Aimee L | SVP, Chief People Officer | Sell | 3,917 | $199.06 | $779.7K | 2,881 |
| Feb 23, 2023↗ | Aravanis Alexander | SVP, Chief Technology Officer | Sell | 5,398 | $201.74 | $1.09M | 5,242 |
| Feb 8, 2023↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 500 | $211.57 | $105.8K | 38,276 |
| Jan 11, 2023↗ | Hoyt Aimee L | SVP, Chief People Officer | Sell | 871 | $205.57 | $179.1K | 2,796 |
| Jan 10, 2023↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 500 | $204.58 | $102.3K | 38,662 |
| Dec 8, 2022↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 500 | $212.63 | $106.3K | 39,162 |
| Nov 8, 2022↗ | Aravanis Alexander | SVP, Chief Technology Officer | Sell | 361 | $218.00 | $78.7K | 2,857 |
| Nov 8, 2022↗ | Hoyt Aimee L | SVP, Chief People Officer | Sell | 1,294 | $223.65 | $289.4K | 3,418 |
| Nov 8, 2022↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 500 | $223.65 | $111.8K | 40,112 |
| Oct 11, 2022↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 500 | $216.59 | $108.3K | 41,333 |
| Jul 7, 2022↗ | Aravanis Alexander | SVP, Chief Technology Officer | Sell | 539 | $200.00 | $107.8K | 3,346 |
| Jun 14, 2022↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 250 | $214.85 | $53.7K | 41,833 |
| May 2, 2022↗ | Dadswell Charles | SVP & General Counsel | Sell | 368 | $300.13 | $110.4K | 7,427 |
| Apr 14, 2022↗ | Hoyt Aimee L | SVP, Chief People Officer | Sell | 2,474 | $350.51 | $867.2K | 7,616 |
| Apr 7, 2022↗ | Febbo Phillip G. | SVP Chief Medical Officer | Sell | 1,988 | $360.01 | $715.7K | 5,774 |
| Mar 30, 2022↗ | Dadswell Charles | SVP & General Counsel | Sell | 368 | $342.83 | $126.2K | 7,795 |
| Jan 13, 2022↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 800 | $425.00 | $340.0K | 39,274 |
| Dec 30, 2021↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 100 | $387.06 | $38.7K | 40,074 |
| Dec 23, 2021↗ | Dadswell Charles | SVP & General Counsel | Sell | 322 | $380.29 | $122.5K | 3,283 |
| Dec 9, 2021↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 100 | $375.00 | $37.5K | 40,174 |
| Nov 24, 2021↗ | Dadswell Charles | SVP, General Counsel | Sell | 314 | $377.86 | $118.6K | 3,605 |
| Nov 16, 2021↗ | Aravanis Alexander | SVP, Chief Technology Officer | Sell | 361 | $386.35 | $139.5K | 4,127 |
| Nov 9, 2021↗ | Febbo Phillip G. | SVP Chief Medical Officer | Sell | 1,000 | $406.83 | $406.8K | 3,015 |
| Nov 4, 2021↗ | Aravanis Alexander | SVP, Chief Technology Officer | Sell | 2,926 | $412.78 | $1.21M | 7,405 |
| Nov 1, 2021↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 100 | $414.35 | $41.4K | 41,256 |
| Oct 28, 2021↗ | Aravanis Alexander | SVP, Chief Technology Officer | Sell | 2,926 | $423.00 | $1.24M | 7,605 |
| Oct 26, 2021↗ | Dadswell Charles | SVP & General Counsel | Sell | 314 | $411.00 | $129.1K | 4,658 |
| Oct 21, 2021↗ | Aravanis Alexander | SVP, Chief Technology Officer | Sell | 2,926 | $411.81 | $1.20M | 12,857 |
| Oct 14, 2021↗ | Aravanis Alexander | SVP, Chief Technology Officer | Sell | 2,926 | $409.21 | $1.20M | 15,960 |
| Sep 30, 2021↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 100 | $418.04 | $41.8K | 41,356 |
| Sep 23, 2021↗ | Dadswell Charles | SVP & General Counsel | Sell | 314 | $436.69 | $137.1K | 4,972 |
| Sep 8, 2021↗ | Hoyt Aimee L | SVP, Chief People Officer | Sell | 3,372 | $432.61 | $1.46M | 6,111 |
| Sep 1, 2021↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 300 | $463.50 | $139.1K | 41,456 |
| Aug 25, 2021↗ | Dadswell Charles | SVP & General Counsel | Sell | 314 | $489.10 | $153.6K | 5,286 |
| Aug 5, 2021↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 1,000 | $500.00 | $500.0K | 41,756 |
| Jul 29, 2021↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 300 | $486.41 | $145.9K | 42,743 |
| Jul 26, 2021↗ | Dadswell Charles | SVP & General Counsel | Sell | 314 | $482.23 | $151.4K | 5,576 |
| Jul 7, 2021↗ | Aravanis Alexander | SVP, Chief Technology Officer | Sell | 539 | $477.59 | $257.4K | 4,679 |
| Jun 30, 2021↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 300 | $478.95 | $143.7K | 43,043 |
| Jun 24, 2021↗ | Dadswell Charles | SVP & General Counsel | Sell | 314 | $461.01 | $144.8K | 5,890 |
| Jun 14, 2021↗ | DORSA CAROLINE | Director | Sell | 1,000 | $450.00 | $450.0K | 8,501 |
| Jun 14, 2021↗ | Febbo Phillip G. | SVP Chief Medical Officer | Sell | 1,000 | $447.59 | $447.6K | 5,151 |
| May 26, 2021↗ | Dadswell Charles | SVP & General Counsel | Sell | 314 | $403.04 | $126.6K | 6,204 |
| May 24, 2021↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 500 | $400.00 | $200.0K | 43,343 |
| May 20, 2021↗ | FLATLEY JAY T | Director | Sell | 4,000 | $379.53 | $1.52M | 148,933 |
| May 6, 2021↗ | FLATLEY JAY T | Director | Sell | 4,000 | $384.15 | $1.54M | 152,933 |
| May 6, 2021↗ | TOUSI SUSAN H | SVP Product Development | Sell | 300 | $381.88 | $114.6K | 43,843 |
| Apr 26, 2021↗ | Dadswell Charles | SVP & General Counsel | Sell | 314 | $402.02 | $126.2K | 6,518 |
| Apr 22, 2021↗ | FLATLEY JAY T | Director | Sell | 4,000 | $401.83 | $1.61M | 156,933 |
| Apr 7, 2021↗ | FLATLEY JAY T | Director | Sell | 4,000 | $423.44 | $1.69M | 160,933 |
| Apr 7, 2021↗ | TOUSI SUSAN H | SVP Product Development | Sell | 800 | $409.41 | $327.5K | 44,643 |
| Mar 24, 2021↗ | Dadswell Charles | SVP & General Counsel | Sell | 314 | $416.24 | $130.7K | 6,832 |
| Mar 18, 2021↗ | FLATLEY JAY T | Director | Sell | 4,000 | $421.06 | $1.68M | 164,933 |
| Mar 9, 2021↗ | TOUSI SUSAN H | SVP Product Development | Sell | 800 | $402.24 | $321.8K | 44,943 |
| Mar 4, 2021↗ | FLATLEY JAY T | Director | Sell | 4,000 | $444.61 | $1.78M | 168,933 |
ILMN Insider Buying Activity
The following table shows recent insider purchases of Illumina, Inc. (ILMN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 11, 2026↗ | Gottlieb Scott | director | Buy | 200 | $117.81 | $23.6K | 12,723 |
| Nov 5, 2025↗ | Gottlieb Scott | Director | Buy | 500 | $122.13 | $61.1K | 12,523 |
| May 14, 2025↗ | Dhingra Ankur | SVP, Chief Financial Officer | Buy | 6,100 | $81.21 | $495.4K | 24,906 |
| May 14, 2025↗ | Thaysen Jacob | Chief Executive Officer | Buy | 12,350 | $80.86 | $998.7K | 83,390 |
| Feb 26, 2024↗ | Thaysen Jacob | Chief Executive Officer | Buy | 7,330 | $135.29 | $991.7K | 14,861 |
ILMN Insider Selling Activity
The following table shows recent insider sales of Illumina, Inc. (ILMN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 24, 2026↗ | Davies Scott M | officer: Chief Legal Officer | Sell | 2,672 | $116.18 | $310.4K | 16,334 |
| Feb 18, 2026↗ | Leckman Patricia | officer: SVP, Chief People Officer | Sell | 2,370 | $116.18 | $275.3K | 16,321 |
| Feb 17, 2026↗ | Ericksen Scott D | VP, Chief Accounting Officer | Sell | 306 | $114.44 | $35.0K | 0 |
| Feb 15, 2026↗ | Barnard Steven | SVP, Chief Technology Officer | Sell | 1,259 | $116.51 | $146.7K | 0 |
| Feb 15, 2026↗ | Davies Scott M | Chief Legal Officer | Sell | 1,037 | $116.51 | $120.8K | 0 |
| Feb 15, 2026↗ | Ericksen Scott D | VP, Chief Accounting Officer | Sell | 694 | $116.51 | $80.9K | 0 |
| Feb 15, 2026↗ | Leckman Patricia | SVP, Chief People Officer | Sell | 3,674 | $116.30 | $427.3K | 0 |
| Feb 15, 2026↗ | Pegels Kevin Carl | Chief of Global Operations | Sell | 1,164 | $116.51 | $135.6K | 0 |
| Feb 15, 2026↗ | Thaysen Jacob | Chief Executive Officer | Sell | 6,544 | $116.51 | $762.4K | 0 |
| Feb 15, 2026↗ | Wedel Christensen Jakob | SVP, Strategy/Corp Development | Sell | 578 | $116.51 | $67.3K | 0 |
| Feb 12, 2026↗ | Barnard Steven | SVP, Chief Technology Officer | Sell | 1,014 | $114.44 | $116.0K | 0 |
| Feb 12, 2026↗ | Davies Scott M | Chief Legal Officer | Sell | 550 | $114.44 | $62.9K | 0 |
| Feb 12, 2026↗ | Leckman Patricia | SVP, Chief People Officer | Sell | 424 | $114.44 | $48.5K | 0 |
| Feb 12, 2026↗ | Pegels Kevin Carl | Chief of Global Operations | Sell | 874 | $114.44 | $100.0K | 0 |
| Feb 12, 2026↗ | Thaysen Jacob | Chief Executive Officer | Sell | 5,470 | $114.44 | $626.0K | 0 |
| Dec 16, 2025↗ | Davies Scott M | Chief Legal Officer | Sell | 323 | $136.09 | $44.0K | 17,887 |
| Dec 9, 2025↗ | Wedel Christensen Jakob | SVP, Strategy/Corp Development | Sell | 549 | $129.27 | $71.0K | 10,952 |
| Nov 18, 2025↗ | ILLUMINA, INC. | Sell | 1,000,000 | $79.85 | $79.85M | 3,502,130 | |
| Nov 9, 2023↗ | Hoyt Aimee L | SVP, Chief People Officer | Sell | 315 | $112.84 | $35.5K | 8,314 |
| Aug 24, 2023↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 500 | $167.04 | $83.5K | 45,524 |
| Jul 26, 2023↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 500 | $190.08 | $95.0K | 46,022 |
| Jun 26, 2023↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 500 | $200.00 | $100.0K | 46,522 |
| May 24, 2023↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 5,000 | $208.59 | $1.04M | 51,822 |
| Mar 3, 2023↗ | Hoyt Aimee L | SVP, Chief People Officer | Sell | 3,917 | $199.06 | $779.7K | 2,881 |
| Feb 23, 2023↗ | Aravanis Alexander | SVP, Chief Technology Officer | Sell | 5,398 | $201.74 | $1.09M | 5,242 |
| Feb 8, 2023↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 500 | $211.57 | $105.8K | 38,276 |
| Jan 11, 2023↗ | Hoyt Aimee L | SVP, Chief People Officer | Sell | 871 | $205.57 | $179.1K | 2,796 |
| Jan 10, 2023↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 500 | $204.58 | $102.3K | 38,662 |
| Dec 8, 2022↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 500 | $212.63 | $106.3K | 39,162 |
| Nov 8, 2022↗ | Aravanis Alexander | SVP, Chief Technology Officer | Sell | 361 | $218.00 | $78.7K | 2,857 |
| Nov 8, 2022↗ | Hoyt Aimee L | SVP, Chief People Officer | Sell | 1,294 | $223.65 | $289.4K | 3,418 |
| Nov 8, 2022↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 500 | $223.65 | $111.8K | 40,112 |
| Oct 11, 2022↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 500 | $216.59 | $108.3K | 41,333 |
| Jul 7, 2022↗ | Aravanis Alexander | SVP, Chief Technology Officer | Sell | 539 | $200.00 | $107.8K | 3,346 |
| Jun 14, 2022↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 250 | $214.85 | $53.7K | 41,833 |
| May 2, 2022↗ | Dadswell Charles | SVP & General Counsel | Sell | 368 | $300.13 | $110.4K | 7,427 |
| Apr 14, 2022↗ | Hoyt Aimee L | SVP, Chief People Officer | Sell | 2,474 | $350.51 | $867.2K | 7,616 |
| Apr 7, 2022↗ | Febbo Phillip G. | SVP Chief Medical Officer | Sell | 1,988 | $360.01 | $715.7K | 5,774 |
| Mar 30, 2022↗ | Dadswell Charles | SVP & General Counsel | Sell | 368 | $342.83 | $126.2K | 7,795 |
| Jan 13, 2022↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 800 | $425.00 | $340.0K | 39,274 |
| Dec 30, 2021↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 100 | $387.06 | $38.7K | 40,074 |
| Dec 23, 2021↗ | Dadswell Charles | SVP & General Counsel | Sell | 322 | $380.29 | $122.5K | 3,283 |
| Dec 9, 2021↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 100 | $375.00 | $37.5K | 40,174 |
| Nov 24, 2021↗ | Dadswell Charles | SVP, General Counsel | Sell | 314 | $377.86 | $118.6K | 3,605 |
| Nov 16, 2021↗ | Aravanis Alexander | SVP, Chief Technology Officer | Sell | 361 | $386.35 | $139.5K | 4,127 |
| Nov 9, 2021↗ | Febbo Phillip G. | SVP Chief Medical Officer | Sell | 1,000 | $406.83 | $406.8K | 3,015 |
| Nov 4, 2021↗ | Aravanis Alexander | SVP, Chief Technology Officer | Sell | 2,926 | $412.78 | $1.21M | 7,405 |
| Nov 1, 2021↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 100 | $414.35 | $41.4K | 41,256 |
| Oct 28, 2021↗ | Aravanis Alexander | SVP, Chief Technology Officer | Sell | 2,926 | $423.00 | $1.24M | 7,605 |
| Oct 26, 2021↗ | Dadswell Charles | SVP & General Counsel | Sell | 314 | $411.00 | $129.1K | 4,658 |
| Oct 21, 2021↗ | Aravanis Alexander | SVP, Chief Technology Officer | Sell | 2,926 | $411.81 | $1.20M | 12,857 |
| Oct 14, 2021↗ | Aravanis Alexander | SVP, Chief Technology Officer | Sell | 2,926 | $409.21 | $1.20M | 15,960 |
| Sep 30, 2021↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 100 | $418.04 | $41.8K | 41,356 |
| Sep 23, 2021↗ | Dadswell Charles | SVP & General Counsel | Sell | 314 | $436.69 | $137.1K | 4,972 |
| Sep 8, 2021↗ | Hoyt Aimee L | SVP, Chief People Officer | Sell | 3,372 | $432.61 | $1.46M | 6,111 |
| Sep 1, 2021↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 300 | $463.50 | $139.1K | 41,456 |
| Aug 25, 2021↗ | Dadswell Charles | SVP & General Counsel | Sell | 314 | $489.10 | $153.6K | 5,286 |
| Aug 5, 2021↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 1,000 | $500.00 | $500.0K | 41,756 |
| Jul 29, 2021↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 300 | $486.41 | $145.9K | 42,743 |
| Jul 26, 2021↗ | Dadswell Charles | SVP & General Counsel | Sell | 314 | $482.23 | $151.4K | 5,576 |
| Jul 7, 2021↗ | Aravanis Alexander | SVP, Chief Technology Officer | Sell | 539 | $477.59 | $257.4K | 4,679 |
| Jun 30, 2021↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 300 | $478.95 | $143.7K | 43,043 |
| Jun 24, 2021↗ | Dadswell Charles | SVP & General Counsel | Sell | 314 | $461.01 | $144.8K | 5,890 |
| Jun 14, 2021↗ | DORSA CAROLINE | Director | Sell | 1,000 | $450.00 | $450.0K | 8,501 |
| Jun 14, 2021↗ | Febbo Phillip G. | SVP Chief Medical Officer | Sell | 1,000 | $447.59 | $447.6K | 5,151 |
| May 26, 2021↗ | Dadswell Charles | SVP & General Counsel | Sell | 314 | $403.04 | $126.6K | 6,204 |
| May 24, 2021↗ | TOUSI SUSAN H | SVP, Chief Commercial Officer | Sell | 500 | $400.00 | $200.0K | 43,343 |
| May 20, 2021↗ | FLATLEY JAY T | Director | Sell | 4,000 | $379.53 | $1.52M | 148,933 |
| May 6, 2021↗ | FLATLEY JAY T | Director | Sell | 4,000 | $384.15 | $1.54M | 152,933 |
| May 6, 2021↗ | TOUSI SUSAN H | SVP Product Development | Sell | 300 | $381.88 | $114.6K | 43,843 |
| Apr 26, 2021↗ | Dadswell Charles | SVP & General Counsel | Sell | 314 | $402.02 | $126.2K | 6,518 |
| Apr 22, 2021↗ | FLATLEY JAY T | Director | Sell | 4,000 | $401.83 | $1.61M | 156,933 |
| Apr 7, 2021↗ | FLATLEY JAY T | Director | Sell | 4,000 | $423.44 | $1.69M | 160,933 |
| Apr 7, 2021↗ | TOUSI SUSAN H | SVP Product Development | Sell | 800 | $409.41 | $327.5K | 44,643 |
| Mar 24, 2021↗ | Dadswell Charles | SVP & General Counsel | Sell | 314 | $416.24 | $130.7K | 6,832 |
| Mar 18, 2021↗ | FLATLEY JAY T | Director | Sell | 4,000 | $421.06 | $1.68M | 164,933 |
| Mar 9, 2021↗ | TOUSI SUSAN H | SVP Product Development | Sell | 800 | $402.24 | $321.8K | 44,943 |
| Mar 4, 2021↗ | FLATLEY JAY T | Director | Sell | 4,000 | $444.61 | $1.78M | 168,933 |
ILMN Insiders
Similar Stocks to ILMN
TMO
Thermo Fisher Scientific Inc.
$176.79B
DHR
Danaher Corporation
$131.71B
IDXX
IDEXX Laboratories, Inc.
$45.61B
IQV
IQVIA Holdings Inc.
$27.65B
NTRA
Natera, Inc.
$26.97B
MTD
Mettler-Toledo International Inc.
$23.86B
DGX
Quest Diagnostics Incorporated
$22.22B
LH
Labcorp Holdings Inc.
$21.87B